<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1d3 20150301//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-journalpublishing1.dtd?><?SourceDTD.Version 39.96?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">PLoS One</journal-id><journal-id journal-id-type="iso-abbrev">PLoS ONE</journal-id><journal-id journal-id-type="publisher-id">plos</journal-id><journal-id journal-id-type="pmc">plosone</journal-id><journal-title-group><journal-title>PLoS ONE</journal-title></journal-title-group><issn pub-type="epub">1932-6203</issn><publisher><publisher-name>Public Library of Science</publisher-name><publisher-loc>San Francisco, CA USA</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">7413401</article-id><article-id pub-id-type="doi">10.1371/journal.pone.0237214</article-id><article-id pub-id-type="publisher-id">PONE-D-19-32770</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Medical Conditions</subject><subj-group><subject>Infectious Diseases</subject><subj-group><subject>Viral Diseases</subject><subj-group><subject>Influenza</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and Life Sciences</subject><subj-group><subject>Molecular Biology</subject><subj-group><subject>Molecular Biology Techniques</subject><subj-group><subject>Artificial Gene Amplification and Extension</subject><subj-group><subject>Polymerase Chain Reaction</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Research and Analysis Methods</subject><subj-group><subject>Molecular Biology Techniques</subject><subj-group><subject>Artificial Gene Amplification and Extension</subject><subj-group><subject>Polymerase Chain Reaction</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Medical Conditions</subject><subj-group><subject>Infectious Diseases</subject><subj-group><subject>Nosocomial Infections</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Organisms</subject><subj-group><subject>Viruses</subject><subj-group><subject>RNA viruses</subject><subj-group><subject>Orthomyxoviruses</subject><subj-group><subject>Influenza viruses</subject><subj-group><subject>Influenza A virus</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Microbiology</subject><subj-group><subject>Medical microbiology</subject><subj-group><subject>Microbial pathogens</subject><subj-group><subject>Viral pathogens</subject><subj-group><subject>Orthomyxoviruses</subject><subj-group><subject>Influenza viruses</subject><subj-group><subject>Influenza A virus</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Pathology and laboratory medicine</subject><subj-group><subject>Pathogens</subject><subj-group><subject>Microbial pathogens</subject><subj-group><subject>Viral pathogens</subject><subj-group><subject>Orthomyxoviruses</subject><subj-group><subject>Influenza viruses</subject><subj-group><subject>Influenza A virus</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Organisms</subject><subj-group><subject>Viruses</subject><subj-group><subject>Viral pathogens</subject><subj-group><subject>Orthomyxoviruses</subject><subj-group><subject>Influenza viruses</subject><subj-group><subject>Influenza A virus</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Critical Care and Emergency Medicine</subject><subj-group><subject>Triage</subject></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Health Care</subject><subj-group><subject>Health Care Providers</subject><subj-group><subject>Physicians</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>People and Places</subject><subj-group><subject>Population Groupings</subject><subj-group><subject>Professions</subject><subj-group><subject>Medical Personnel</subject><subj-group><subject>Physicians</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Medical Conditions</subject><subj-group><subject>Infectious Diseases</subject><subj-group><subject>Respiratory Infections</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Medical Conditions</subject><subj-group><subject>Respiratory Disorders</subject><subj-group><subject>Respiratory Infections</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Pulmonology</subject><subj-group><subject>Respiratory Disorders</subject><subj-group><subject>Respiratory Infections</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and Health Sciences</subject><subj-group><subject>Critical Care and Emergency Medicine</subject></subj-group></subj-group></article-categories><title-group><article-title>Factors associated with single-room assignment among patients admitted through the emergency department during influenza epidemics</article-title><alt-title alt-title-type="running-head">Single room assignment for ED patients, during Influenza Season</alt-title></title-group><contrib-group><contrib contrib-type="author"><contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0002-7538-3320</contrib-id><name><surname>Bouzid</surname><given-names>Donia</given-names></name><role content-type="https://casrai.org/credit/">Conceptualization</role><role content-type="https://casrai.org/credit/">Data curation</role><role content-type="https://casrai.org/credit/">Formal analysis</role><role content-type="https://casrai.org/credit/">Investigation</role><role content-type="https://casrai.org/credit/">Methodology</role><role content-type="https://casrai.org/credit/">Writing &#x02013; original draft</role><xref ref-type="aff" rid="aff001"><sup>1</sup></xref><xref ref-type="aff" rid="aff002"><sup>2</sup></xref><xref ref-type="corresp" rid="cor001">*</xref></contrib><contrib contrib-type="author"><name><surname>Visseaux</surname><given-names>Benoit</given-names></name><role content-type="https://casrai.org/credit/">Supervision</role><role content-type="https://casrai.org/credit/">Validation</role><xref ref-type="aff" rid="aff001"><sup>1</sup></xref><xref ref-type="aff" rid="aff003"><sup>3</sup></xref></contrib><contrib contrib-type="author"><name><surname>Perozziello</surname><given-names>Anne</given-names></name><role content-type="https://casrai.org/credit/">Methodology</role><xref ref-type="aff" rid="aff001"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Lescure</surname><given-names>Xavier</given-names></name><role content-type="https://casrai.org/credit/">Writing &#x02013; review &#x00026; editing</role><xref ref-type="aff" rid="aff001"><sup>1</sup></xref><xref ref-type="aff" rid="aff004"><sup>4</sup></xref><xref ref-type="aff" rid="aff005"><sup>5</sup></xref></contrib><contrib contrib-type="author"><name><surname>Duval</surname><given-names>Xavier</given-names></name><role content-type="https://casrai.org/credit/">Writing &#x02013; review &#x00026; editing</role><xref ref-type="aff" rid="aff001"><sup>1</sup></xref><xref ref-type="aff" rid="aff006"><sup>6</sup></xref></contrib><contrib contrib-type="author"><name><surname>Casalino</surname><given-names>Enrique</given-names></name><role content-type="https://casrai.org/credit/">Conceptualization</role><xref ref-type="aff" rid="aff001"><sup>1</sup></xref><xref ref-type="aff" rid="aff002"><sup>2</sup></xref></contrib><contrib contrib-type="author"><name><surname>Lucet</surname><given-names>Jean Christophe</given-names></name><role content-type="https://casrai.org/credit/">Conceptualization</role><role content-type="https://casrai.org/credit/">Methodology</role><role content-type="https://casrai.org/credit/">Supervision</role><role content-type="https://casrai.org/credit/">Validation</role><role content-type="https://casrai.org/credit/">Writing &#x02013; review &#x00026; editing</role><xref ref-type="aff" rid="aff001"><sup>1</sup></xref><xref ref-type="aff" rid="aff006"><sup>6</sup></xref></contrib><contrib contrib-type="author"><collab>on behalf of the ED influenza management study group</collab><xref ref-type="author-notes" rid="fn001"><sup>&#x000b6;</sup></xref></contrib></contrib-group><aff id="aff001"><label>1</label>
<addr-line>IAME, INSERM, Universit&#x000e9; de Paris, Paris, France</addr-line></aff><aff id="aff002"><label>2</label>
<addr-line>Emergency Department, AP-HP, University Hospital Bichat-Claude Bernard, Paris, France</addr-line></aff><aff id="aff003"><label>3</label>
<addr-line>AP-HP, University Hospital Bichat-Claude Bernard, Virology, Paris, France</addr-line></aff><aff id="aff004"><label>4</label>
<addr-line>Infectious Disease Department, AP-HP, University Hospital Bichat-Claude Bernard, Paris, France</addr-line></aff><aff id="aff005"><label>5</label>
<addr-line>Clinical Investigation Center, AP-HP, University Hospital Bichat-Claude Bernard, Paris, France</addr-line></aff><aff id="aff006"><label>6</label>
<addr-line>Infection Control Unit, AP-HP, University Hospital Bichat-Claude, Paris, France</addr-line></aff><contrib-group><contrib contrib-type="editor"><name><surname>Seale</surname><given-names>Holly</given-names></name><role>Editor</role><xref ref-type="aff" rid="edit1"/></contrib></contrib-group><aff id="edit1"><addr-line>University of New South Wales, AUSTRALIA</addr-line></aff><author-notes><fn fn-type="COI-statement" id="coi001"><p><bold>Competing Interests: </bold>The authors have declared that no competing interests exist.</p></fn><fn fn-type="other" id="fn001"><p>&#x000b6; Membership of the ED influenza management study group list in the Acknowledgments.</p></fn><corresp id="cor001">* E-mail: <email>donia.bouzid@aphp.fr</email></corresp></author-notes><pub-date pub-type="epub"><day>7</day><month>8</month><year>2020</year></pub-date><pub-date pub-type="collection"><year>2020</year></pub-date><volume>15</volume><issue>8</issue><elocation-id>e0237214</elocation-id><history><date date-type="received"><day>26</day><month>11</month><year>2019</year></date><date date-type="accepted"><day>22</day><month>7</month><year>2020</year></date></history><permissions><copyright-statement>&#x000a9; 2020 Bouzid et al</copyright-statement><copyright-year>2020</copyright-year><copyright-holder>Bouzid et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="pone.0237214.pdf"/><abstract><sec id="sec001"><title>Introduction</title><p>Every winter, emergency departments (EDs) face overcrowding with patients presenting influenza-like symptoms, and organisational issues such as single room assignment and droplet precautions to avoid hospital-acquired influenza. Our main objective was to assess the impact of PCR results and patient&#x02019;s severity on single room assignment.</p></sec><sec id="sec002"><title>Methods</title><p>All patients admitted to Bichat-Claude Bernard Hospital through the ED and tested for influenza by PCR (GenXpert, Cepheid) or (FilmArray, BioM&#x000e9;rieux) on a nasopharyngeal swab were retrospectively included during three influenza seasons (2015&#x02013;2018.</p></sec><sec id="sec003"><title>Results</title><p>Of 1,330 included patients, 278 (20.9%) had a positive PCR for influenza. The median time to obtain a PCR result was 19 hours, and 238 (18.3%) patients were assigned a single room. Among patients with positive and negative influenza PCR, 22.3% and 16.7% were assigned a single room (p = 0.03). The multivariable analysis was performed on the two first epidemic periods, excluding the third epidemic because of the concomitant use of influenza immune-chromatic test. Only level 1 of the Emergency severity index (ESI) (aOR, 1.9; 95% CI, 1.3&#x02013;2.8; p &#x0003c; 0.01) was associated with single-room assignment. PCR result was not statistically associated with the decision of single room assignment (aOR, 1.4; 95%CI, 1.0&#x02013;1.4; p = 0.07).</p></sec><sec id="sec004"><title>Conclusion</title><p>A PCR positive for influenza was not significantly associated with single-room assignment. Less than one quarter of influenza patients were adequately assigned a single room, likely due to the long turnaround time of PCR result and other conflicting indications for single room-assignment. Accelerating biological diagnosis could improve single-room assignment.</p></sec></abstract><funding-group><funding-statement>The author(s) received no specific funding for this work.</funding-statement></funding-group><counts><fig-count count="1"/><table-count count="3"/><page-count count="9"/></counts><custom-meta-group><custom-meta id="data-availability"><meta-name>Data Availability</meta-name><meta-value>The authors are not allowed to share the data publicly as, according to French ethical laws, the raw data of epidemiological study collected as part of the medical follow-up on the framework of standard medical care cannot be shared, even anonymously, without a specific ethical committee approval. However these data are secured in our laboratory system, as required by the ISO15189 certification of our laboratory, and can be shared on request approved by an adequate ethical committee. Interested researchers may submit queries related to data access to the <email>urcest@chusa.jussieu.fr</email>. Additionally, queries may be sent to the authors at the following email: <email>benoit.visseaux@aphp.fr</email> and <email>donia.bouzid@aphp.fr</email>.</meta-value></custom-meta></custom-meta-group></article-meta><notes><title>Data Availability</title><p>The authors are not allowed to share the data publicly as, according to French ethical laws, the raw data of epidemiological study collected as part of the medical follow-up on the framework of standard medical care cannot be shared, even anonymously, without a specific ethical committee approval. However these data are secured in our laboratory system, as required by the ISO15189 certification of our laboratory, and can be shared on request approved by an adequate ethical committee. Interested researchers may submit queries related to data access to the <email>urcest@chusa.jussieu.fr</email>. Additionally, queries may be sent to the authors at the following email: <email>benoit.visseaux@aphp.fr</email> and <email>donia.bouzid@aphp.fr</email>.</p></notes></front><body><sec sec-type="intro" id="sec005"><title>Introduction</title><p>Influenza is a huge public health problem causing 650 000 deaths every year worldwide [<xref rid="pone.0237214.ref001" ref-type="bibr">1</xref>]. Annual winter epidemics of influenza also cause a large number of hospitalization, about 140,000 to 960,000 each year in the US [<xref rid="pone.0237214.ref002" ref-type="bibr">2</xref>], that challenge the hospital management. Though most people recover within few days, influenza can cause various and serious respiratory, cardiac or neurological complications among the elderly or other fragile patients.</p><p>During each annual winter epidemic, emergency departments (EDs) face overcrowding, with patients presenting influenza-like illness (ILI) or suspicion of pneumonia. Thus, EDs must deal with organisational issues related to patients&#x02019; isolation and the risk of viral nosocomial transmission in the context of limited availability of single rooms. A study assessing the relationship between admission to double-occupancy rooms and hospital-acquired influenza showed a higher risk of acquiring influenza among patients admitted in a double-occupancy room compared to those placed in a single room [<xref rid="pone.0237214.ref003" ref-type="bibr">3</xref>]. In another study, the same team estimated that the hospital-acquired influenza risk was largely increased when the roommate presented an ILI [<xref rid="pone.0237214.ref004" ref-type="bibr">4</xref>]. Patients&#x02019; isolation with single-room assignment is the cornerstone of droplet precautions along with wearing medical masks and hand hygiene [<xref rid="pone.0237214.ref005" ref-type="bibr">5</xref>]. However, in most settings, single rooms are rare and not available for all patients presenting an ILI. Rapid biological confirmation is thus recommended to help with isolation and single-room assignment decisions in hospital settings.</p><p>Polymerase chain reaction testing (PCR) has the highest sensitivity compared to other diagnostic tests [<xref rid="pone.0237214.ref006" ref-type="bibr">6</xref>&#x02013;<xref rid="pone.0237214.ref009" ref-type="bibr">9</xref>]. However, PCR is currently mostly performed in the laboratory and has a long turnaround time, which can delay and alter single-room assignment for patients with ILI. Point of care (PoC) PCR assays decreased the time to result, hospitalisation and mortality rates [<xref rid="pone.0237214.ref010" ref-type="bibr">10</xref>] but without improvement regarding the proportion of influenza-positive patients correctly assigned to single rooms.</p><p>A recent study assessing the usefulness of multiplex PCR as PoC testing in the ED showed that the percentage of patients assigned to a single room among patients positive for influenza or respiratory syncytial virus was higher, although not significantly, in those with PoC testing than in those with laboratory testing, owed to a shorter PCR turnaround time (37.1 vs 2.3 hours) [<xref rid="pone.0237214.ref011" ref-type="bibr">11</xref>]. As in other studies assessing PoC usefulness [<xref rid="pone.0237214.ref010" ref-type="bibr">10</xref>,<xref rid="pone.0237214.ref012" ref-type="bibr">12</xref>,<xref rid="pone.0237214.ref013" ref-type="bibr">13</xref>], this study did not assess for the potential others factors possibly involved in room assignment.</p><p>Our main objective was to assess the association of influenza PCR and disease severity on single-room assignment, during the first 48 hours of admission, for patients seeking the ED during influenza epidemics.</p></sec><sec sec-type="materials|methods" id="sec006"><title>Methods</title><p>We conducted a retrospective study at the ED of Bichat-Claude Bernard university Hospital. This is a tertiary hospital in Paris, serving a population of more than 350,000 inhabitants. The ED receives more than 80,000 visits per year. The hospital includes 455 single rooms and 276 double rooms.</p><p>All patients admitted to the hospital through the ED and tested for influenza PCR during three consecutive influenza epidemics between 2015 and 2018 were included. During the study period, two PCR were used: GenXpert<sup>&#x000ae;</sup> (Cepheid, Sunnyvale, CA, USA) or FilmArray<sup>&#x000ae;</sup> RP panel (BioFire<sup>&#x000ae;</sup>, BioM&#x000e9;rieux, Marcy-L&#x02019;&#x000e9;toile, France). All PCR assays were performed in the virology laboratory during opening hours (8 a.m. to 6 p.m. from Monday to Friday, and 8 a.m. to 1 p.m. on Saturday).</p><p>The definition of influenza epidemic periods was based on the French national surveillance system [<xref rid="pone.0237214.ref014" ref-type="bibr">14</xref>]. According to the national surveillance system, the first epidemic period extended from 25 January 2016 to 17 April 2016, the second from 5 December 2016 to 12 February 2017, and the third from 4 December 2017 to 17 April 2018.</p><p>Virological data were extracted from the virology laboratory database and merged with the ED database, containing clinical data, and to the medical information system, containing duration of hospital stay and room assignment. Variables included demographic characteristics, level of triage according to the Emergency Severity Index (ESI) (ranging from 1 requiring immediate, life-saving intervention without delay to 5 meaning stable, without any resources anticipated except oral or topical medications, or prescriptions) [<xref rid="pone.0237214.ref015" ref-type="bibr">15</xref>,<xref rid="pone.0237214.ref016" ref-type="bibr">16</xref>], PCR turnaround time, ward of admission, and room assignment.</p><p>The primary outcome was the single- or double-room assignment at 48 hours of hospital stay, whatever the type of unit of stay, either a clinical ward or the downstream ED unit.</p><p>Variables were summarised as frequency and proportion for categorical variables and median and interquartile range for continuous variables. Continuous variables were converted into categorical variables using their interquartile range. We compared the characteristics of the three epidemics using the Kruskal-Wallis test for quantitative variables and the &#x003c7;<sup>2</sup> test for the qualitative variables. Logistic regression was used to identify factors influencing the primary outcome in the multivariable analysis including: age, PCR results, weekend shifts, time between ER sampling and PCR results. During the third period, ED physicians used a point of care testing with an immune-chromatographic method in addition to PCR, therefore shifting the association between time to PCR results and room assignment. All tests were performed with a type I error of 0.05. The data management and statistical analysis were performed using Stata15<sup>&#x000ae;</sup>.</p><p>The study design has been approved by the Bichat Claude Bernard ethic committee (N&#x000b0;2019&#x02013;029).</p></sec><sec sec-type="results" id="sec007"><title>Results</title><p>Among the 2563 patients, 1233 were not included because they were previously included in the study or not admitted after their visit at the ED. Thus, we included 1330 patients: 319, 601, and 410 during the first, second, and third epidemic period, respectively (<xref ref-type="fig" rid="pone.0237214.g001">Fig 1</xref>). A total of 278 patients (20.9%) tested positive for influenza with PCR.</p><fig id="pone.0237214.g001" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0237214.g001</object-id><label>Fig 1</label><caption><title>Study flowchart.</title></caption><graphic xlink:href="pone.0237214.g001"/></fig><p>The sex ratio was similar across the three periods; several differences were observed (<xref rid="pone.0237214.t001" ref-type="table">Table 1</xref>). Patients were younger during the first period than during the second and third periods (p &#x0003c; 0.001); only influenza type A virus was identified during the second period, while both influenza A and B were detected during the first and third periods; the triage level distribution was also significantly different over the three periods (p = 0.02); however, the proportion of level-1 triage, representing the 221 most severe patients (16.6%) with either hemodynamic or respiratory failure was not statistically significant among the three periods (p = 0.49). Finally, the distribution of ward admission was significantly different between, with more patients admitted to a surgical ward during the second period as compared to the first and third periods. Overall, 36 (2.7%) patients were admitted to the intensive care unit (ICU) from the ED.</p><table-wrap id="pone.0237214.t001" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0237214.t001</object-id><label>Table 1</label><caption><title>Characteristics of included patients with ILI, during the three winter epidemics (2015&#x02013;2018) at Bichat Claude Bernard Hospital.</title></caption><alternatives><graphic id="pone.0237214.t001g" xlink:href="pone.0237214.t001"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th align="left" rowspan="2" colspan="1">Characteristics (n, %)</th><th align="center" rowspan="1" colspan="1">Winter 2015&#x02013;2016 (319 patients)</th><th align="center" rowspan="1" colspan="1">Winter 2016&#x02013;2017 (601 patients)</th><th align="center" rowspan="1" colspan="1">Winter 2017&#x02013;2018 (410 patients)</th><th align="center" rowspan="2" colspan="1">p value</th></tr><tr><th align="center" rowspan="1" colspan="1">(n,%)</th><th align="center" rowspan="1" colspan="1">(n,%)</th><th align="center" rowspan="1" colspan="1">(n,%)</th></tr></thead><tbody><tr><td align="left" style="background-color:#D9D9D9" rowspan="1" colspan="1">Gender</td><td align="center" style="background-color:#D9D9D9" rowspan="1" colspan="1"/><td align="center" style="background-color:#D9D9D9" rowspan="1" colspan="1"/><td align="center" style="background-color:#D9D9D9" rowspan="1" colspan="1"/><td align="char" char="." style="background-color:#D9D9D9" rowspan="1" colspan="1">0.76</td></tr><tr><td align="left" style="background-color:#D9D9D9" rowspan="1" colspan="1">&#x02003;Female (n = 629)</td><td align="center" style="background-color:#D9D9D9" rowspan="1" colspan="1">147 (46.1)</td><td align="center" style="background-color:#D9D9D9" rowspan="1" colspan="1">297(49.41)</td><td align="center" style="background-color:#D9D9D9" rowspan="1" colspan="1">185 (45.2)</td><td align="center" style="background-color:#D9D9D9" rowspan="1" colspan="1"/></tr><tr><td align="left" style="background-color:#D9D9D9" rowspan="1" colspan="1">&#x02003;Male (n = 701)</td><td align="center" style="background-color:#D9D9D9" rowspan="1" colspan="1">172 (53.9)</td><td align="center" style="background-color:#D9D9D9" rowspan="1" colspan="1">304 (50.6)</td><td align="center" style="background-color:#D9D9D9" rowspan="1" colspan="1">225 (54.8)</td><td align="center" style="background-color:#D9D9D9" rowspan="1" colspan="1"/></tr><tr><td align="left" style="background-color:#D9D9D9" rowspan="1" colspan="1">Age (years, median, IQR)</td><td align="center" style="background-color:#D9D9D9" rowspan="1" colspan="1">73.9 (61.2&#x02013;82.6)</td><td align="left" style="background-color:#D9D9D9" rowspan="1" colspan="1">79.6 (66.6&#x02013;87.7)</td><td align="center" style="background-color:#D9D9D9" rowspan="1" colspan="1">77.4 (64.2&#x02013;87.9)</td><td align="char" char="." style="background-color:#D9D9D9" rowspan="1" colspan="1">&#x0003c;0.001</td></tr><tr><td align="left" style="background-color:#D9D9D9" rowspan="1" colspan="1">&#x02003;&#x0003c; 65 (n = 346)</td><td align="center" style="background-color:#D9D9D9" rowspan="1" colspan="1">96 (30.1)</td><td align="center" style="background-color:#D9D9D9" rowspan="1" colspan="1">139 (23.1)</td><td align="center" style="background-color:#D9D9D9" rowspan="1" colspan="1">111 (27.1)</td><td align="center" style="background-color:#D9D9D9" rowspan="1" colspan="1"/></tr><tr><td align="left" style="background-color:#D9D9D9" rowspan="1" colspan="1">&#x02003;65&#x02013;75 (n = 259)</td><td align="center" style="background-color:#D9D9D9" rowspan="1" colspan="1">73 (22.8)</td><td align="center" style="background-color:#D9D9D9" rowspan="1" colspan="1">110 (18.3)</td><td align="center" style="background-color:#D9D9D9" rowspan="1" colspan="1">76 (18.5)</td><td align="center" style="background-color:#D9D9D9" rowspan="1" colspan="1"/></tr><tr><td align="left" style="background-color:#D9D9D9" rowspan="1" colspan="1">&#x02003;76&#x02013;85 (n = 310)</td><td align="center" style="background-color:#D9D9D9" rowspan="1" colspan="1">82 (25.7)</td><td align="center" style="background-color:#D9D9D9" rowspan="1" colspan="1">136 (22.6)</td><td align="center" style="background-color:#D9D9D9" rowspan="1" colspan="1">92 (15.3)</td><td align="center" style="background-color:#D9D9D9" rowspan="1" colspan="1"/></tr><tr><td align="left" style="background-color:#D9D9D9" rowspan="1" colspan="1">&#x02003;&#x0003e; 85 (n = 415)</td><td align="center" style="background-color:#D9D9D9" rowspan="1" colspan="1">68 (21.3)</td><td align="center" style="background-color:#D9D9D9" rowspan="1" colspan="1">216 (35.9)</td><td align="center" style="background-color:#D9D9D9" rowspan="1" colspan="1">131 (31.6)</td><td align="center" style="background-color:#D9D9D9" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Triage level:</td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="char" char="." rowspan="1" colspan="1">0.01</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;Level 1 (n = 221)</td><td align="center" rowspan="1" colspan="1">50 (15.7)</td><td align="center" rowspan="1" colspan="1">99 (16.5)</td><td align="center" rowspan="1" colspan="1">72 (17.5)</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;Level 2 (n = 377)</td><td align="center" rowspan="1" colspan="1">104 (32.6)</td><td align="center" rowspan="1" colspan="1">147 (24.5)</td><td align="center" rowspan="1" colspan="1">126 (30.7)</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;Level 3-4-5 (n = 732)</td><td align="center" rowspan="1" colspan="1">165 (51.7)</td><td align="center" rowspan="1" colspan="1">355 (59.1)</td><td align="center" rowspan="1" colspan="1">212 (51.7)</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" style="background-color:#D9D9D9" rowspan="1" colspan="1">Ward admission</td><td align="center" style="background-color:#D9D9D9" rowspan="1" colspan="1"/><td align="center" style="background-color:#D9D9D9" rowspan="1" colspan="1"/><td align="center" style="background-color:#D9D9D9" rowspan="1" colspan="1"/><td align="char" char="." style="background-color:#D9D9D9" rowspan="1" colspan="1">&#x0003c;0.001</td></tr><tr><td align="left" style="background-color:#D9D9D9" rowspan="1" colspan="1">&#x02003;Medical (n = 942)</td><td align="center" style="background-color:#D9D9D9" rowspan="1" colspan="1">236 (73.9)</td><td align="center" style="background-color:#D9D9D9" rowspan="1" colspan="1">393 (65.4)</td><td align="center" style="background-color:#D9D9D9" rowspan="1" colspan="1">313 (76.3)</td><td align="center" style="background-color:#D9D9D9" rowspan="1" colspan="1"/></tr><tr><td align="left" style="background-color:#D9D9D9" rowspan="1" colspan="1">&#x02003;Surgical (n = 156)</td><td align="center" style="background-color:#D9D9D9" rowspan="1" colspan="1">22 (6.9)</td><td align="center" style="background-color:#D9D9D9" rowspan="1" colspan="1">93 (15.4)</td><td align="center" style="background-color:#D9D9D9" rowspan="1" colspan="1">41 (10)</td><td align="center" style="background-color:#D9D9D9" rowspan="1" colspan="1"/></tr><tr><td align="left" style="background-color:#D9D9D9" rowspan="1" colspan="1">&#x02003;ICU (n = 36)</td><td align="center" style="background-color:#D9D9D9" rowspan="1" colspan="1">11 (3.4)</td><td align="center" style="background-color:#D9D9D9" rowspan="1" colspan="1">13 (2.1)</td><td align="center" style="background-color:#D9D9D9" rowspan="1" colspan="1">12 (2.9)</td><td align="center" style="background-color:#D9D9D9" rowspan="1" colspan="1"/></tr><tr><td align="left" style="background-color:#D9D9D9" rowspan="1" colspan="1">&#x02003;Transferred (n = 196)</td><td align="center" style="background-color:#D9D9D9" rowspan="1" colspan="1">50 (15.7)</td><td align="center" style="background-color:#D9D9D9" rowspan="1" colspan="1">102 (16.9)</td><td align="center" style="background-color:#D9D9D9" rowspan="1" colspan="1">44 (10.7)</td><td align="center" style="background-color:#D9D9D9" rowspan="1" colspan="1"/></tr></tbody></table></alternatives><table-wrap-foot><fn id="t001fn001"><p>Abbreviations: PCR, Polymerase Chain Reaction; IQR, Inter Quartile Range.</p></fn></table-wrap-foot></table-wrap><p>The median turnaround times between ED sampling and PCR result were 19.3, 19.2, and 15.7 hours during the first, second, and third period, respectively (<xref rid="pone.0237214.t002" ref-type="table">Table 2</xref>). In total, 238 (17.8%) patients were assigned to a single room within the first 48 hours after admission. Among those 238 patients with IL assigned a single room, 62 (26.1%) had a positive PCR.</p><table-wrap id="pone.0237214.t002" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0237214.t002</object-id><label>Table 2</label><caption><title>Summary of PCR results and room assignment for patients with ILI during the three winter epidemics (2015&#x02013;2018), at Bichat Claude Bernard Hospital.</title></caption><alternatives><graphic id="pone.0237214.t002g" xlink:href="pone.0237214.t002"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th align="left" rowspan="1" colspan="1">Characteristics (n, %)</th><th align="center" rowspan="1" colspan="1">Winter 2015&#x02013;2016 (n = 319)</th><th align="center" rowspan="1" colspan="1">Winter 2016&#x02013;2017 (n = 601)</th><th align="center" rowspan="1" colspan="1">Winter 2017&#x02013;2018 (n = 410)</th><th align="left" rowspan="1" colspan="1">p value</th></tr></thead><tbody><tr><td align="left" style="background-color:#D9D9D9" rowspan="1" colspan="1">Positive PCR (n = 278)</td><td align="center" style="background-color:#D9D9D9" rowspan="1" colspan="1">58 (18.2)</td><td align="center" style="background-color:#D9D9D9" rowspan="1" colspan="1">136 (22.6)</td><td align="center" style="background-color:#D9D9D9" rowspan="1" colspan="1">85 (21.2)</td><td align="left" style="background-color:#D9D9D9" rowspan="1" colspan="1"/></tr><tr><td align="left" style="background-color:#D9D9D9" rowspan="1" colspan="1">&#x02003;Influenza A (n = 208)</td><td align="center" style="background-color:#D9D9D9" rowspan="1" colspan="1">30 (51.7)</td><td align="center" style="background-color:#D9D9D9" rowspan="1" colspan="1">136 (100)</td><td align="center" style="background-color:#D9D9D9" rowspan="1" colspan="1">42 (49.4)</td><td align="char" char="." style="background-color:#D9D9D9" rowspan="1" colspan="1">&#x0003c;0.001</td></tr><tr><td align="left" style="background-color:#D9D9D9" rowspan="1" colspan="1">&#x02003;Influenza B (n = 71)</td><td align="center" style="background-color:#D9D9D9" rowspan="1" colspan="1">28 (48.27)</td><td align="center" style="background-color:#D9D9D9" rowspan="1" colspan="1">0 (0)</td><td align="center" style="background-color:#D9D9D9" rowspan="1" colspan="1">43 (50.5)</td><td align="left" style="background-color:#D9D9D9" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Time between sampling and PCR result (hours, median, interquartile range)</td><td align="center" rowspan="1" colspan="1">19.3 (7.2&#x02013;36.6)</td><td align="center" rowspan="1" colspan="1">19.2 (9.7&#x02013;29)</td><td align="center" rowspan="1" colspan="1">15.6 (4.8&#x02013;27.4)</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="center" rowspan="1" colspan="1">&#x02264; 6 h</td><td align="center" rowspan="1" colspan="1">71 (22.2%)</td><td align="center" rowspan="1" colspan="1">110 (18.3)</td><td align="center" rowspan="1" colspan="1">134 (32.7)</td><td align="char" char="." rowspan="1" colspan="1">&#x0003c;0.001</td></tr><tr><td align="center" rowspan="1" colspan="1">&#x0003e; 6h</td><td align="center" rowspan="1" colspan="1">248 (77.8%)</td><td align="center" rowspan="1" colspan="1">491 (81.7)</td><td align="center" rowspan="1" colspan="1">476 (67.3)</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" style="background-color:#D9D9D9" rowspan="1" colspan="1">Room assignment</td><td align="center" style="background-color:#D9D9D9" rowspan="1" colspan="1"/><td align="center" style="background-color:#D9D9D9" rowspan="1" colspan="1"/><td align="center" style="background-color:#D9D9D9" rowspan="1" colspan="1"/><td align="left" style="background-color:#D9D9D9" rowspan="1" colspan="1"/></tr><tr><td align="left" style="background-color:#D9D9D9" rowspan="1" colspan="1">&#x02003;Single room (n = 238)</td><td align="center" style="background-color:#D9D9D9" rowspan="1" colspan="1">82 (25.7)</td><td align="center" style="background-color:#D9D9D9" rowspan="1" colspan="1">141 (23.5)</td><td align="center" style="background-color:#D9D9D9" rowspan="1" colspan="1">15 (3.6)</td><td align="char" char="." style="background-color:#D9D9D9" rowspan="1" colspan="1">&#x0003c;0.001</td></tr><tr><td align="left" style="background-color:#D9D9D9" rowspan="1" colspan="1">&#x02003;Double room (n = 1092)</td><td align="center" style="background-color:#D9D9D9" rowspan="1" colspan="1">237 (74.3)</td><td align="center" style="background-color:#D9D9D9" rowspan="1" colspan="1">460 (76.5)</td><td align="center" style="background-color:#D9D9D9" rowspan="1" colspan="1">395 (96.4)</td><td align="left" style="background-color:#D9D9D9" rowspan="1" colspan="1"/></tr></tbody></table></alternatives><table-wrap-foot><fn id="t002fn001"><p>Abbreviations: PCR, Polymerase Chain Reaction; IQR, Inter Quartile Range.</p></fn></table-wrap-foot></table-wrap><p>During the third epidemic, ED physicians had access to an influenza point of care test, which made this epidemic not comparable to the other epidemic. Indeed we observed an interaction between this third period and PCR turnaround time, therefore we have chosen to exclude the third epidemic from the logistic regression analysis. There was no association between single-room assignment and positive PCR result (<xref rid="pone.0237214.t003" ref-type="table">Table 3</xref>). The only factors associated with single-room assignment in the univariable analysis were the level-1 triage and weekend visits to the ED. We did not observe statistically significant difference between day or night visits and the type of room assignment.</p><table-wrap id="pone.0237214.t003" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0237214.t003</object-id><label>Table 3</label><caption><title>Univariable and multivariable analysis of factors associated with a single room assignment for patients with ILI during two winter epidemics (2015&#x02013;2017) at Bichat Claude Bernard hospital.</title></caption><alternatives><graphic id="pone.0237214.t003g" xlink:href="pone.0237214.t003"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th align="left" rowspan="2" colspan="1">Factors (n, %)</th><th align="center" colspan="2" rowspan="1">Room assignment</th><th align="center" rowspan="1" colspan="1">Univariable analysis</th><th align="center" rowspan="1" colspan="1"/><th align="center" rowspan="1" colspan="1">Multivariable analysis</th><th align="center" rowspan="1" colspan="1"/></tr><tr><th align="center" rowspan="1" colspan="1">Single (n = 223)</th><th align="center" rowspan="1" colspan="1">Double (n = 697)</th><th align="center" rowspan="1" colspan="1">RR (95%CI)</th><th align="center" rowspan="1" colspan="1">p value</th><th align="center" rowspan="1" colspan="1">OR (95%CI)</th><th align="center" rowspan="1" colspan="1">p value</th></tr></thead><tbody><tr><td align="left" style="background-color:#D9D9D9" rowspan="1" colspan="1">Age (years)<xref ref-type="table-fn" rid="t003fn002">*</xref></td><td align="center" style="background-color:#D9D9D9" rowspan="1" colspan="1"/><td align="center" style="background-color:#D9D9D9" rowspan="1" colspan="1"/><td align="center" style="background-color:#D9D9D9" rowspan="1" colspan="1"/><td align="char" char="." style="background-color:#D9D9D9" rowspan="1" colspan="1">0.21</td><td align="center" style="background-color:#D9D9D9" rowspan="1" colspan="1"/><td align="center" style="background-color:#D9D9D9" rowspan="1" colspan="1"/></tr><tr><td align="center" style="background-color:#D9D9D9" rowspan="1" colspan="1">&#x02003;&#x02264; 75 (<italic>n = 418</italic>)</td><td align="center" style="background-color:#D9D9D9" rowspan="1" colspan="1">93 (41.7%)</td><td align="center" style="background-color:#D9D9D9" rowspan="1" colspan="1">324 (46.5%)</td><td align="center" style="background-color:#D9D9D9" rowspan="1" colspan="1">1</td><td align="center" style="background-color:#D9D9D9" rowspan="1" colspan="1"/><td align="center" style="background-color:#D9D9D9" rowspan="1" colspan="1"/><td align="center" style="background-color:#D9D9D9" rowspan="1" colspan="1"/></tr><tr><td align="center" style="background-color:#D9D9D9" rowspan="1" colspan="1">&#x02003;&#x0003e; 75 (<italic>n = 502</italic>)</td><td align="center" style="background-color:#D9D9D9" rowspan="1" colspan="1">130 (58.3%)</td><td align="center" style="background-color:#D9D9D9" rowspan="1" colspan="1">373 (53.5%)</td><td align="center" style="background-color:#D9D9D9" rowspan="1" colspan="1">1.2 (0.9&#x02013;1.4)</td><td align="center" style="background-color:#D9D9D9" rowspan="1" colspan="1"/><td align="center" style="background-color:#D9D9D9" rowspan="1" colspan="1"/><td align="center" style="background-color:#D9D9D9" rowspan="1" colspan="1"/></tr><tr><td align="left" style="background-color:#D9D9D9" rowspan="1" colspan="1">Male gender <italic>(n = 476</italic>)</td><td align="center" style="background-color:#D9D9D9" rowspan="1" colspan="1">117 (52.5%)</td><td align="center" style="background-color:#D9D9D9" rowspan="1" colspan="1">359 (51.5%)</td><td align="center" style="background-color:#D9D9D9" rowspan="1" colspan="1">1.0 (0.8&#x02013;1.3)</td><td align="char" char="." style="background-color:#D9D9D9" rowspan="1" colspan="1">0.82</td><td align="center" style="background-color:#D9D9D9" rowspan="1" colspan="1"/><td align="center" style="background-color:#D9D9D9" rowspan="1" colspan="1"/></tr><tr><td align="left" style="background-color:#D9D9D9" rowspan="1" colspan="1">PCR<xref ref-type="table-fn" rid="t003fn002">*</xref></td><td align="center" style="background-color:#D9D9D9" rowspan="1" colspan="1"/><td align="center" style="background-color:#D9D9D9" rowspan="1" colspan="1"/><td align="center" style="background-color:#D9D9D9" rowspan="1" colspan="1"/><td align="center" style="background-color:#D9D9D9" rowspan="1" colspan="1"/><td align="center" style="background-color:#D9D9D9" rowspan="1" colspan="1"/><td align="center" style="background-color:#D9D9D9" rowspan="1" colspan="1"/></tr><tr><td align="left" style="background-color:#D9D9D9" rowspan="1" colspan="1">&#x02003;Negative (<italic>n = 1052</italic>)</td><td align="center" style="background-color:#D9D9D9" rowspan="1" colspan="1">167(74.8%)</td><td align="left" style="background-color:#D9D9D9" rowspan="1" colspan="1">558 (80.0%)</td><td align="left" style="background-color:#D9D9D9" rowspan="1" colspan="1">1</td><td align="center" style="background-color:#D9D9D9" rowspan="1" colspan="1"/><td align="left" style="background-color:#D9D9D9" rowspan="1" colspan="1">1</td><td align="center" style="background-color:#D9D9D9" rowspan="1" colspan="1"/></tr><tr><td align="left" style="background-color:#D9D9D9" rowspan="1" colspan="1">&#x02003;Positive (<italic>n = 278</italic>)</td><td align="center" style="background-color:#D9D9D9" rowspan="1" colspan="1">56 (25.2%)</td><td align="center" style="background-color:#D9D9D9" rowspan="1" colspan="1">139 (20.0%)</td><td align="center" style="background-color:#D9D9D9" rowspan="1" colspan="1">1.3 (0.9&#x02013;1.6)</td><td align="char" char="." style="background-color:#D9D9D9" rowspan="1" colspan="1">0.08</td><td align="center" style="background-color:#D9D9D9" rowspan="1" colspan="1">1.4 (1.0&#x02013;1.9)</td><td align="char" char="." style="background-color:#D9D9D9" rowspan="1" colspan="1">0.07</td></tr><tr><td align="left" rowspan="1" colspan="1">Triage level<xref ref-type="table-fn" rid="t003fn002">*</xref></td><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;Level 2-3-4-5 (<italic>n = 771</italic>)</td><td align="left" rowspan="1" colspan="1">170 (76.3%)</td><td align="left" rowspan="1" colspan="1">601 (86.3%)</td><td align="left" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">1</td><td align="center" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;Level 1 (<italic>n = 149</italic>)</td><td align="left" rowspan="1" colspan="1">53 (23.7%)</td><td align="left" rowspan="1" colspan="1">96 (13.7%)</td><td align="left" rowspan="1" colspan="1">1.61 (1.2&#x02013;2.1)</td><td align="char" char="." rowspan="1" colspan="1">&#x0003c;0.01</td><td align="center" rowspan="1" colspan="1">1.9 (1.3&#x02013;2.8)</td><td align="char" char="." rowspan="1" colspan="1">&#x0003c;0.01</td></tr><tr><td align="left" style="background-color:#D9D9D9" rowspan="1" colspan="1">ER sampling to PCR results<xref ref-type="table-fn" rid="t003fn002">*</xref></td><td align="center" style="background-color:#D9D9D9" rowspan="1" colspan="1"/><td align="center" style="background-color:#D9D9D9" rowspan="1" colspan="1"/><td align="center" style="background-color:#D9D9D9" rowspan="1" colspan="1"/><td align="center" style="background-color:#D9D9D9" rowspan="1" colspan="1"/><td align="center" style="background-color:#D9D9D9" rowspan="1" colspan="1"/><td align="center" style="background-color:#D9D9D9" rowspan="1" colspan="1"/></tr><tr><td align="left" style="background-color:#D9D9D9" rowspan="1" colspan="1">&#x02264;6h (<italic>n = 181</italic>)</td><td align="center" style="background-color:#D9D9D9" rowspan="1" colspan="1">35 (15.7%)</td><td align="center" style="background-color:#D9D9D9" rowspan="1" colspan="1">146 (20.9%)</td><td align="center" style="background-color:#D9D9D9" rowspan="1" colspan="1">1</td><td align="center" style="background-color:#D9D9D9" rowspan="1" colspan="1"/><td align="center" style="background-color:#D9D9D9" rowspan="1" colspan="1"/><td align="center" style="background-color:#D9D9D9" rowspan="1" colspan="1"/></tr><tr><td align="left" style="background-color:#D9D9D9" rowspan="1" colspan="1">&#x0003e; 6h (<italic>n = 739</italic>)</td><td align="center" style="background-color:#D9D9D9" rowspan="1" colspan="1">188 (84.3%)</td><td align="center" style="background-color:#D9D9D9" rowspan="1" colspan="1">551 (79.1%)</td><td align="center" style="background-color:#D9D9D9" rowspan="1" colspan="1">1.3 (0.9&#x02013;1.8)</td><td align="char" char="." style="background-color:#D9D9D9" rowspan="1" colspan="1">0.09</td><td align="center" style="background-color:#D9D9D9" rowspan="1" colspan="1"/><td align="center" style="background-color:#D9D9D9" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Weekends<xref ref-type="table-fn" rid="t003fn002">*</xref> (<italic>n = 329</italic>)</td><td align="center" rowspan="1" colspan="1">66 (29.6%)</td><td align="center" rowspan="1" colspan="1">162 (23.2%)</td><td align="center" rowspan="1" colspan="1">1.3 (1.1&#x02013;1.6)</td><td align="char" char="." rowspan="1" colspan="1">0.04</td><td align="center" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" style="background-color:#D9D9D9" rowspan="1" colspan="1">Type of shift</td><td align="center" style="background-color:#D9D9D9" rowspan="1" colspan="1"/><td align="center" style="background-color:#D9D9D9" rowspan="1" colspan="1"/><td align="center" style="background-color:#D9D9D9" rowspan="1" colspan="1"/><td align="center" style="background-color:#D9D9D9" rowspan="1" colspan="1"/><td align="center" style="background-color:#D9D9D9" rowspan="1" colspan="1"/><td align="center" style="background-color:#D9D9D9" rowspan="1" colspan="1"/></tr><tr><td align="left" style="background-color:#D9D9D9" rowspan="1" colspan="1">&#x02003;Day (<italic>n = 647</italic>)</td><td align="center" style="background-color:#D9D9D9" rowspan="1" colspan="1">155 (69.5%)</td><td align="center" style="background-color:#D9D9D9" rowspan="1" colspan="1">492 (70.6%</td><td align="center" style="background-color:#D9D9D9" rowspan="1" colspan="1">1</td><td align="center" style="background-color:#D9D9D9" rowspan="1" colspan="1"/><td align="center" style="background-color:#D9D9D9" rowspan="1" colspan="1"/><td align="center" style="background-color:#D9D9D9" rowspan="1" colspan="1"/></tr><tr><td align="left" style="background-color:#D9D9D9" rowspan="1" colspan="1">&#x02003;Night (<italic>n = 273</italic>)</td><td align="center" style="background-color:#D9D9D9" rowspan="1" colspan="1">68 (30.5%)</td><td align="center" style="background-color:#D9D9D9" rowspan="1" colspan="1">)205 (29.4%)</td><td align="center" style="background-color:#D9D9D9" rowspan="1" colspan="1">1.1 (0.9&#x02013;1.1)</td><td align="char" char="." style="background-color:#D9D9D9" rowspan="1" colspan="1">0.70</td><td align="center" style="background-color:#D9D9D9" rowspan="1" colspan="1"/><td align="center" style="background-color:#D9D9D9" rowspan="1" colspan="1"/></tr></tbody></table></alternatives><table-wrap-foot><fn id="t003fn001"><p>Abbreviations: PCR, Polymerase Chain Reaction.</p></fn><fn id="t003fn002"><p>* Included in multivariable analysis.</p></fn></table-wrap-foot></table-wrap><p>In the multivariable analysis. Only level 1 of triage according to ESI was associated to single-room assignment (adjusted OR,1.9; 95%CI, 1.3&#x02013;2.8, p&#x0003c;0.01), while a positive PCR result for influenza was not (aOR, 1.46; 95% CI, 1.0&#x02013;1.9; p = 0.07); turnaround time and weekends were no longer statistically associated to single-room assignment.</p></sec><sec sec-type="conclusions" id="sec008"><title>Discussion</title><p>In this 3-year observational study in a large teaching hospital, we showed that patients&#x02019; severity based on ESI level 1 was the only factor associated with single room. Only 25.2% of admitted patients presenting a positive PCR for influenza were assigned to a single room. These results underline that patient&#x02019;s isolation remains insufficient, despite a large number of 455 single rooms in our hospital.</p><p>Previous studies have shown that single-room assignment is efficient in reducing nosocomial infections, specifically influenza [<xref rid="pone.0237214.ref017" ref-type="bibr">17</xref>,<xref rid="pone.0237214.ref018" ref-type="bibr">18</xref>], but the availability of single rooms is often still beyond the needs during influenza seasons [<xref rid="pone.0237214.ref019" ref-type="bibr">19</xref>]. Despite the fact that newly built hospitals may tend to include larger numbers of single rooms [<xref rid="pone.0237214.ref020" ref-type="bibr">20</xref>], the placement of patients with high-risk respiratory viral infection, notably influenza infection, remains a challenge. In addition, the proportion of influenza infections is usually low among patients presenting an ILI during outbreak periods, about 20% in our study and in previous works [<xref rid="pone.0237214.ref021" ref-type="bibr">21</xref>,<xref rid="pone.0237214.ref022" ref-type="bibr">22</xref>]. Thus, a rapid virological diagnosis is required to appropriately decide which patient with ILI should be assigned to an available single room. However, we did not find an association between the time to result, defined as the delay between ED sampling and PCR results, and single-room assignment. This may be largely explained by a minimal time to result in our study always being longer than 3 hours due to sample transportation to the laboratory and PCR delay. Due to these delays and the limited opening hours of the laboratory, the median time to result was 19 hours. This might remain too long to allow the consideration of the result by the ED physician at the decision-making time. This is in line with a recent randomised study that showed that performing influenza PoC PCR improved the proportion of patients isolated with a confirmed respiratory virus infection (17 vs 9%, p = 0.02) and reduced the hospital length of stay [<xref rid="pone.0237214.ref011" ref-type="bibr">11</xref>]. Furthermore, in a post-hoc analysis, the same authors showed that a PCR result obtained in less than 2 hours reduced the duration of antibiotic treatment by half and reduced the length of hospital stay by about 3 days [<xref rid="pone.0237214.ref023" ref-type="bibr">23</xref>]. Further studies are required to evaluate the impact of PoC influenza PCR and placement in single rooms.</p><p>In the current work, single-room assignment was associated with patient severity, defined as level-1 triage of the ESI. It has been shown that severe patients have a longer length of stay in the ED [<xref rid="pone.0237214.ref024" ref-type="bibr">24</xref>], but no previous study has assessed the impact of the ESI on single-room assignment in the downstream unit.</p><p>To our knowledge, our study is the first to assess factors leading to single-room assignment in adult patients presenting an ILI. Due to the study&#x02019;s retrospective and observational design, our results reflect the actual practice in a French ED and contrast with a recent study [<xref rid="pone.0237214.ref011" ref-type="bibr">11</xref>]. As any patient presenting with ILI is required to be placed in a single room pending PCR result, our low proportion of influenza-positive patients in single room was surprising and highlight the difficulties of such organization in the emergency context.</p><p>Our work presents several limitations. Firstly, it was a retrospective and monocentric study. During the study period, several changes occurred in the global management of patients presenting an ILI, especially during the third epidemic period: a new multiplex PCR was available and allowed faster results, with a median turnaround time of 15.6 vs 19.3 hours for the previous epidemics. In addition, a new algorithm for the influenza diagnosis based on an immuno-chromatographic rapid influenza diagnostic test (RIDT) was applied in the ED at the same period, in parallel to the PCR testing at the virology laboratory. Based on this algorithm, all patients presenting an ILI were initially tested using a PoC RIDT; only patients admitted in the hospital were tested by a PCR in the virology laboratory. The observed poor accuracy of the RIDT might explain the lower frequency of single-room assignment of patients with a positive PCR. Excluding the third epidemic period, the proportion of patients with positive PCR assigned a single room was higher, at 24%. This distinct period also illustrates that single room assignment for influenza-positive patients remains a year to year challenge that could not be resolved by a rapid but less reliable PoC method. Secondly, we could not retrieve the detailed occupancy rates during the epidemics, and the actual availability of single rooms remained unknown. This parameter should, intuitively, also be linked to single-room assignment. We also did not know if some influenza positive patients may have been rarely cohorted in double rooms. Finally, the ED database lacked information for two critical time points: the time of decision for hospital admission and the time of actual information of the ED physician of the PCR result. The proportion of patients with a positive influenza PCR assigned to a single room remained low over the three periods. However, in a 2018&#x02013;2019 pilot study conducted in our ED with a Multiplex PCR point of care method, allowing a result within one hour, 80% of patients were assigned to a single room [<xref rid="pone.0237214.ref025" ref-type="bibr">25</xref>]. Taken together with the result of the current study, this suggests that PCR turnaround time should be greatly shortened for decision making of room assignment.</p></sec><sec sec-type="conclusions" id="sec009"><title>Conclusion</title><p>Hospital-acquired influenza is an old and well-known threat that the physicians must tackle by applying preventive measures based on accurate and rapid diagnosis. The optimal protocol to optimise both costs and patient isolation management is yet to be precisely identified. Our results highlighted that a large majority of influenza-positive patients were still assigned double-occupancy rooms and it is likely due to the long turnaround time of PCR results. As most ED physician decisions are made in a data frame of a few hours, shortening the time to result by implementing point of care PCR should improve patients&#x02019; management, facilitate the ED organisation, and improve isolation and droplet precautions during the overcrowded influenza season.</p></sec><sec sec-type="supplementary-material" id="sec010"><title>Supporting information</title><supplementary-material content-type="local-data" id="pone.0237214.s001"><label>S1 File</label><caption><p>(DOCX)</p></caption><media xlink:href="pone.0237214.s001.docx"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material></sec></body><back><ack><p>The study group is composed of: NADHIRA FIDOUH (Bichat Claude Bernard Virology Laboratory), Dr VITTIAORAT ING (Bichat Claude Bernard, Emergency Department), Dr MA&#x000c9;VA RENOUX (Bichat Claude Bernard, Emergency Department),Dr LAURE FALQUE PIERROTIN (Bichat Claude Bernard, Emergency Department),Dr ROMAIN HELLMANN (Bichat Claude Bernard, Emergency Department), Dr LUISA COLOSI (Bichat Claude Bernard, Emergency Department),Dr ST&#x000c9;PHANIE ANTONIOL POSTIC (Bichat Claude Bernard, Emergency Department), Dr THOMAS PAVLOVSKY (Bichat Claude Bernard Emergency Department).</p></ack><glossary><title>Abbreviations</title><def-list><def-item><term>D</term><def><p>Emergency department</p></def></def-item><def-item><term>ESI</term><def><p>Emergency severity index</p></def></def-item><def-item><term>ICU</term><def><p>Intensive care unit</p></def></def-item><def-item><term>ILI</term><def><p>influenza like illness</p></def></def-item><def-item><term>PCR</term><def><p>Polymerase Chain Reaction</p></def></def-item><def-item><term>POCT</term><def><p>Point of care test</p></def></def-item><def-item><term>RIDT</term><def><p>Rapid influenza diagnostic test</p></def></def-item></def-list></glossary><ref-list><title>References</title><ref id="pone.0237214.ref001"><label>1</label><mixed-citation publication-type="other">Up to 650 000 people die of respiratory diseases linked to seasonal flu each year. <ext-link ext-link-type="uri" xlink:href="http://www.who.int/news-room/detail/14-12-2017-up-to-650-000-people-die-of-respiratory-diseases-linked-to-seasonal-flu-each-year">http://www.who.int/news-room/detail/14-12-2017-up-to-650-000-people-die-of-respiratory-diseases-linked-to-seasonal-flu-each-year</ext-link>. Accessed 29 May 2018.</mixed-citation></ref><ref id="pone.0237214.ref002"><label>2</label><mixed-citation publication-type="other">Disease Burden of Influenza | CDC. 2019. <ext-link ext-link-type="uri" xlink:href="https://www.cdc.gov/flu/about/burden/index.html">https://www.cdc.gov/flu/about/burden/index.html</ext-link>. Accessed 23 January 2019.</mixed-citation></ref><ref id="pone.0237214.ref003"><label>3</label><mixed-citation publication-type="journal"><name><surname>Munier-Marion</surname><given-names>E</given-names></name>, <name><surname>B&#x000e9;net</surname><given-names>T</given-names></name>, <name><surname>R&#x000e9;gis</surname><given-names>C</given-names></name>, <name><surname>Lina</surname><given-names>B</given-names></name>, <name><surname>Morfin</surname><given-names>F</given-names></name>, <name><surname>Vanhems</surname><given-names>P</given-names></name>. <article-title>Hospitalization in double-occupancy rooms and the risk of hospital-acquired influenza: a prospective cohort study</article-title>. <source>Clinical Microbiology and Infection</source>
<year>2016</year>; <volume>22</volume>:<fpage>461.e7</fpage>&#x02013;<lpage>461.e9</lpage>.</mixed-citation></ref><ref id="pone.0237214.ref004"><label>4</label><mixed-citation publication-type="journal"><name><surname>Vanhems</surname><given-names>P</given-names></name>, <name><surname>Voirin</surname><given-names>N</given-names></name>, <name><surname>Roche</surname><given-names>S</given-names></name>, <etal>et al</etal>
<article-title>Risk of influenza-like illness in an acute health care setting during community influenza epidemics in 2004&#x02013;2005, 2005&#x02013;2006, and 2006&#x02013;2007: a prospective study</article-title>. <source>Arch Intern Med</source>
<year>2011</year>; <volume>171</volume>:<fpage>151</fpage>&#x02013;<lpage>157</lpage>. <pub-id pub-id-type="doi">10.1001/archinternmed.2010.500</pub-id>
<?supplied-pmid 21263105?><pub-id pub-id-type="pmid">21263105</pub-id></mixed-citation></ref><ref id="pone.0237214.ref005"><label>5</label><mixed-citation publication-type="journal"><name><surname>Kirkland</surname><given-names>KB</given-names></name>, <name><surname>Weinstein</surname><given-names>JM</given-names></name>. <article-title>Adverse effects of contact isolation</article-title>. <source>Lancet</source>
<year>1999</year>; <volume>354</volume>:<fpage>1177</fpage>&#x02013;<lpage>1178</lpage>. <pub-id pub-id-type="doi">10.1016/S0140-6736(99)04196-3</pub-id>
<?supplied-pmid 10513715?><pub-id pub-id-type="pmid">10513715</pub-id></mixed-citation></ref><ref id="pone.0237214.ref006"><label>6</label><mixed-citation publication-type="journal"><name><surname>Chan</surname><given-names>MCW</given-names></name>, <name><surname>Lee</surname><given-names>N</given-names></name>, <name><surname>Ngai</surname><given-names>KLK</given-names></name>, <name><surname>Leung</surname><given-names>TF</given-names></name>, <name><surname>Chan</surname><given-names>PKS</given-names></name>. <article-title>Clinical and virologic factors associated with reduced sensitivity of rapid influenza diagnostic tests in hospitalized elderly patients and young children</article-title>. <source>J Clin Microbiol</source>
<year>2014</year>; <volume>52</volume>:<fpage>497</fpage>&#x02013;<lpage>501</lpage>. <pub-id pub-id-type="doi">10.1128/JCM.02316-13</pub-id>
<?supplied-pmid 24478479?><pub-id pub-id-type="pmid">24478479</pub-id></mixed-citation></ref><ref id="pone.0237214.ref007"><label>7</label><mixed-citation publication-type="other">Rapid Influenza Diagnostic Tests | Seasonal Influenza (Flu) | CDC. 2017. <ext-link ext-link-type="uri" xlink:href="https://www.cdc.gov/flu/professionals/diagnosis/clinician_guidance_ridt.htm">https://www.cdc.gov/flu/professionals/diagnosis/clinician_guidance_ridt.htm</ext-link>. Accessed 29 May 2018.</mixed-citation></ref><ref id="pone.0237214.ref008"><label>8</label><mixed-citation publication-type="other">Information on Rapid Molecular Assays, RT-PCR, and other Molecular Assays for Diagnosis of Influenza Virus Infection | Seasonal Influenza (Flu) | CDC. 2018. <ext-link ext-link-type="uri" xlink:href="https://www.cdc.gov/flu/professionals/diagnosis/molecular-assays.htm">https://www.cdc.gov/flu/professionals/diagnosis/molecular-assays.htm</ext-link>. Accessed 4 June 2018.</mixed-citation></ref><ref id="pone.0237214.ref009"><label>9</label><mixed-citation publication-type="other">Rapid Diagnostic Testing for Influenza: Information for Clinical Laboratory Directors | CDC. 2019. <ext-link ext-link-type="uri" xlink:href="https://www.cdc.gov/flu/professionals/diagnosis/rapidlab.htm">https://www.cdc.gov/flu/professionals/diagnosis/rapidlab.htm</ext-link>. Accessed 27 February 2019.</mixed-citation></ref><ref id="pone.0237214.ref010"><label>10</label><mixed-citation publication-type="journal"><name><surname>You</surname><given-names>JHS</given-names></name>, <name><surname>Tam</surname><given-names>L-P</given-names></name>, <name><surname>Lee</surname><given-names>NLS</given-names></name>. <article-title>Cost-effectiveness of molecular point-of-care testing for influenza viruses in elderly patients at ambulatory care setting</article-title>. <source>PLoS ONE</source>
<year>2017</year>; <volume>12</volume>:<fpage>e0182091</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pone.0182091</pub-id>
<?supplied-pmid 28750092?><pub-id pub-id-type="pmid">28750092</pub-id></mixed-citation></ref><ref id="pone.0237214.ref011"><label>11</label><mixed-citation publication-type="journal"><name><surname>Brendish</surname><given-names>NJ</given-names></name>, <name><surname>Malachira</surname><given-names>AK</given-names></name>, <name><surname>Armstrong</surname><given-names>L</given-names></name>, <etal>et al</etal>
<article-title>Routine molecular point-of-care testing for respiratory viruses in adults presenting to hospital with acute respiratory illness (ResPOC): a pragmatic, open-label, randomised controlled trial</article-title>. <source>Lancet Respir Med</source>
<year>2017</year>; <volume>5</volume>:<fpage>401</fpage>&#x02013;<lpage>411</lpage>. <pub-id pub-id-type="doi">10.1016/S2213-2600(17)30120-0</pub-id>
<?supplied-pmid 28392237?><pub-id pub-id-type="pmid">28392237</pub-id></mixed-citation></ref><ref id="pone.0237214.ref012"><label>12</label><mixed-citation publication-type="journal"><name><surname>Rogan</surname><given-names>DT</given-names></name>, <name><surname>Kochar</surname><given-names>MS</given-names></name>, <name><surname>Yang</surname><given-names>S</given-names></name>, <name><surname>Quinn</surname><given-names>JV</given-names></name>. <article-title>Impact of Rapid Molecular Respiratory Virus Testing on Real-Time Decision Making in a Pediatric Emergency Department</article-title>. <source>J Mol Diagn</source>
<year>2017</year>; <volume>19</volume>:<fpage>460</fpage>&#x02013;<lpage>467</lpage>. <pub-id pub-id-type="doi">10.1016/j.jmoldx.2017.01.009</pub-id>
<?supplied-pmid 28341587?><pub-id pub-id-type="pmid">28341587</pub-id></mixed-citation></ref><ref id="pone.0237214.ref013"><label>13</label><mixed-citation publication-type="journal"><name><surname>Lacroix</surname><given-names>S</given-names></name>, <name><surname>Vrignaud</surname><given-names>B</given-names></name>, <name><surname>Avril</surname><given-names>E</given-names></name>, <etal>et al</etal>
<article-title>Impact of rapid influenza diagnostic test on physician estimation of viral infection probability in paediatric emergency department during epidemic period</article-title>. <source>J Clin Virol</source>
<year>2015</year>; <volume>72</volume>:<fpage>141</fpage>&#x02013;<lpage>145</lpage>. <pub-id pub-id-type="doi">10.1016/j.jcv.2015.08.002</pub-id>
<?supplied-pmid 26513764?><pub-id pub-id-type="pmid">26513764</pub-id></mixed-citation></ref><ref id="pone.0237214.ref014"><label>14</label><mixed-citation publication-type="other">Donn&#x000e9;es de surveillance / Grippe: g&#x000e9;n&#x000e9;ralit&#x000e9;s / Grippe / Maladies &#x000e0; pr&#x000e9;vention vaccinale / Maladies infectieuses / Dossiers th&#x000e9;matiques / Accueil. <ext-link ext-link-type="uri" xlink:href="http://invs.santepubliquefrance.fr/Dossiers-thematiques/Maladies-infectieuses/Maladies-a-prevention-vaccinale/Grippe/Grippe-generalites/Donnees-de-surveillance">http://invs.santepubliquefrance.fr/Dossiers-thematiques/Maladies-infectieuses/Maladies-a-prevention-vaccinale/Grippe/Grippe-generalites/Donnees-de-surveillance</ext-link>. Accessed 31 October 2018.</mixed-citation></ref><ref id="pone.0237214.ref015"><label>15</label><mixed-citation publication-type="journal"><name><surname>Eitel</surname><given-names>DR</given-names></name>, <name><surname>Travers</surname><given-names>DA</given-names></name>, <name><surname>Rosenau</surname><given-names>AM</given-names></name>, <name><surname>Gilboy</surname><given-names>N</given-names></name>, <name><surname>Wuerz</surname><given-names>RC</given-names></name>. <article-title>The emergency severity index triage algorithm version 2 is reliable and valid</article-title>. <source>Acad Emerg Med</source>
<year>2003</year>; <volume>10</volume>:<fpage>1070</fpage>&#x02013;<lpage>1080</lpage>. <pub-id pub-id-type="doi">10.1111/j.1553-2712.2003.tb00577.x</pub-id>
<?supplied-pmid 14525740?><pub-id pub-id-type="pmid">14525740</pub-id></mixed-citation></ref><ref id="pone.0237214.ref016"><label>16</label><mixed-citation publication-type="other">Emergency Severity Index (ESI): A Triage Tool for Emergency Department Care, Version 4: 114.</mixed-citation></ref><ref id="pone.0237214.ref017"><label>17</label><mixed-citation publication-type="journal"><name><surname>Chaudhury</surname><given-names>H</given-names></name>, <name><surname>Mahmood</surname><given-names>A</given-names></name>, <name><surname>Valente</surname><given-names>M</given-names></name>. <article-title>Advantages and Disadvantages of Single-Versus Multiple-Occupancy Rooms in Acute Care Environments: A Review and Analysis of the Literature</article-title>. <source>Environment and Behavior</source>
<year>2005</year>; <volume>37</volume>:<fpage>760</fpage>&#x02013;<lpage>786</lpage>.</mixed-citation></ref><ref id="pone.0237214.ref018"><label>18</label><mixed-citation publication-type="journal"><name><surname>Halaby</surname><given-names>T</given-names></name>, <name><surname>Al Naiemi</surname><given-names>N</given-names></name>, <name><surname>Beishuizen</surname><given-names>B</given-names></name>, <etal>et al</etal>
<article-title>Impact of single room design on the spread of multi-drug resistant bacteria in an intensive care unit</article-title>. <source>Antimicrob Resist Infect Control</source>
<year>2017</year>; <volume>6</volume>:<fpage>117</fpage>
<pub-id pub-id-type="doi">10.1186/s13756-017-0275-z</pub-id>
<?supplied-pmid 29177048?><pub-id pub-id-type="pmid">29177048</pub-id></mixed-citation></ref><ref id="pone.0237214.ref019"><label>19</label><mixed-citation publication-type="journal"><name><surname>Baier</surname><given-names>C</given-names></name>, <name><surname>Linderkamp</surname><given-names>C</given-names></name>, <name><surname>Beilken</surname><given-names>A</given-names></name>, <etal>et al</etal>
<article-title>Influenza and respiratory syncytial virus screening for the detection of asymptomatically infected patients in hematology and oncology</article-title>. <source>GMS Hyg Infect Control</source>
<year>2018</year>; <volume>13</volume>
<ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6234716/">https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6234716/</ext-link>. Accessed 29 January 2020.</mixed-citation></ref><ref id="pone.0237214.ref020"><label>20</label><mixed-citation publication-type="journal"><name><surname>Simon</surname><given-names>M</given-names></name>, <name><surname>Maben</surname><given-names>J</given-names></name>, <name><surname>Murrells</surname><given-names>T</given-names></name>, <name><surname>Griffiths</surname><given-names>P</given-names></name>. <article-title>Is single room hospital accommodation associated with differences in healthcare-associated infection, falls, pressure ulcers or medication errors? A natural experiment with non-equivalent controls</article-title>. <source>J Health Serv Res Policy</source>
<year>2016</year>; <volume>21</volume>:<fpage>147</fpage>&#x02013;<lpage>155</lpage>. <pub-id pub-id-type="doi">10.1177/1355819615625700</pub-id>
<?supplied-pmid 26811373?><pub-id pub-id-type="pmid">26811373</pub-id></mixed-citation></ref><ref id="pone.0237214.ref021"><label>21</label><mixed-citation publication-type="journal"><name><surname>Canavaggio</surname><given-names>P</given-names></name>, <name><surname>Boutolleau</surname><given-names>D</given-names></name>, <name><surname>Goulet</surname><given-names>H</given-names></name>, <name><surname>Riou</surname><given-names>B</given-names></name>, <name><surname>Hausfater</surname><given-names>P</given-names></name>. <article-title>Procalcitonin for clinical decisions on influenza-like illness in emergency department during influenza a(H1N1)2009 pandemic</article-title>. <source>Biomarkers</source>
<year>2018</year>; <volume>23</volume>:<fpage>10</fpage>&#x02013;<lpage>13</lpage>. <pub-id pub-id-type="doi">10.1080/1354750X.2016.1276626</pub-id>
<?supplied-pmid 28010128?><pub-id pub-id-type="pmid">28010128</pub-id></mixed-citation></ref><ref id="pone.0237214.ref022"><label>22</label><mixed-citation publication-type="journal"><name><surname>Caselton</surname><given-names>D</given-names></name>, <name><surname>Arunga</surname><given-names>G</given-names></name>, <name><surname>Emukule</surname><given-names>G</given-names></name>, <etal>et al</etal>
<article-title>Does the length of specimen storage affect influenza testing results by real-time reverse transcription-polymerase chain reaction? an analysis of influenza surveillance specimens, 2008 to 2010</article-title>. <source>Euro Surveill</source>
<year>2014</year>; <volume>19</volume>.</mixed-citation></ref><ref id="pone.0237214.ref023"><label>23</label><mixed-citation publication-type="journal"><name><surname>Brendish</surname><given-names>NJ</given-names></name>, <name><surname>Malachira</surname><given-names>AK</given-names></name>, <name><surname>Beard</surname><given-names>KR</given-names></name>, <name><surname>Ewings</surname><given-names>S</given-names></name>, <name><surname>Clark</surname><given-names>TW</given-names></name>. <article-title>Impact of turnaround time on outcome with point-of-care testing for respiratory viruses: a post hoc analysis from a randomised controlled trial</article-title>. <source>European Respiratory Journal</source>
<year>2018</year>; <volume>52</volume>:<fpage>1800555</fpage>
<pub-id pub-id-type="doi">10.1183/13993003.00555-2018</pub-id>
<?supplied-pmid 29946003?><pub-id pub-id-type="pmid">29946003</pub-id></mixed-citation></ref><ref id="pone.0237214.ref024"><label>24</label><mixed-citation publication-type="journal"><name><surname>Hern&#x000e1;ndez Ruip&#x000e9;rez</surname><given-names>T</given-names></name>, <name><surname>Leal Costa</surname><given-names>C</given-names></name>, <name><surname>de G Ad&#x000e1;nez Mart&#x000ed;nez</surname><given-names>M</given-names></name>, <name><surname>Garc&#x000ed;a P&#x000e9;rez</surname><given-names>B</given-names></name>, <name><surname>Nova L&#x000f3;pez</surname><given-names>D</given-names></name>, <name><surname>D&#x000ed;az Agea</surname><given-names>JL</given-names></name>. [<article-title>Evidence of the validity of the Emergency Severity Index for triage in a general hospital emergency department</article-title>]. <source>Emergencias</source>
<year>2015</year>; <volume>27</volume>:<fpage>301</fpage>&#x02013;<lpage>306</lpage>. <?supplied-pmid 29087054?><pub-id pub-id-type="pmid">29087054</pub-id></mixed-citation></ref><ref id="pone.0237214.ref025"><label>25</label><mixed-citation publication-type="journal"><name><surname>Bouzid</surname><given-names>D</given-names></name>, <name><surname>Lucet</surname><given-names>J-C</given-names></name>, <name><surname>Duval</surname><given-names>X</given-names></name>, <etal>et al</etal>
<article-title>Multiplex PCR implementation as point-of-care testing in a French emergency department</article-title>. <source>J Hosp Infect</source>
<year>2020</year>;</mixed-citation></ref></ref-list></back></article>